Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) has a beta value of 1.39 and has seen 159.5 million shares traded in the recent trading session. The company, currently valued at $3.43M, closed the recent trade at $0.38 per share which meant it gained $0.17 on the day or 81.29% during that session. The QNRX stock price is -313.16% off its 52-week high price of $1.57 and 44.74% above the 52-week low of $0.21. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.41 million shares traded. The 3-month trading volume is 5.38 million shares.
The consensus among analysts is that Quoin Pharmaceuticals Ltd ADR (QNRX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.12.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Sporting 81.29% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QNRX stock price touched $0.38 or saw a rise of 2.56%. Year-to-date, Quoin Pharmaceuticals Ltd ADR shares have moved -41.05%, while the 5-day performance has seen it change 30.03%. Over the past 30 days, the shares of Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) have changed 30.03%. Short interest in the company has seen 0.87 million shares shorted with days to cover at 0.1.
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
The company’s shares have lost -22.19% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -143.98% over the past 5 years.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR is expected to release its next earnings report on 2025-Mar-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
Insiders own 7.08% of the company shares, while shares held by institutions stand at 7.51% with a share float percentage of 8.08%. Investors are also buoyed by the number of investors in a company, with Quoin Pharmaceuticals Ltd ADR having a total of 15.0 institutions that hold shares in the company.
